The FDA released a much-anticipated draft guidance on how makers of rare disease genetic medicines can leverage a platform ...
Two new drug applications (NDA) for ulixacaltamide in essential tremor (ET) and for relutrigine in SCN2A and SCN8A developmental and epileptic ...
Biotech dealmaking is increasingly defined by a clear strategic shift: Pharmaceutical companies are prioritizing de-risked, late-stage assets with human clinical validation rather than speculative ...
Today, INOVAIT, Canada’s image-guided therapy and artificial intelligence network, is announcing a call for applications for the Winter 2026 Pilot Fund. The Pilot Fund is a non-dilutive funding ...
Abstract: Lung cancer accounts for 18% of all cancer-related deaths in the United States, leading the list. Surgical removal of small tumors remains challenging and current treatments are not ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. In response to mounting concerns about safety of artificial intelligence (AI) chatbots in ...
“Together, these findings support a beneficial role for CD47 knockdown in alleviating age-associated metabolic dysfunction through coordinated effects across multiple organs” “Together, these findings ...
Post-traumatic stress disorder (PTSD) is among the most challenging mental health conditions to treat effectively. While traditional therapies help many people, a significant portion continue to ...
The Food and Drug Administration agreed to accept the NDA application for the approval of Celcuity Inc's (NASDAQ: CELC) advanced breast cancer therapy, gedatolisib. The stock already prices in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results